HomeCompareTDSGF vs PLD

TDSGF vs PLD: Dividend Comparison 2026

TDSGF yields 5555.56% · PLD yields 3.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TDSGF wins by $173383299298066.09M in total portfolio value
10 years
TDSGF
TDSGF
● Live price
5555.56%
Share price
$0.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$173383299298072.00M
Annual income
$167,453,967,894,000,300,000.00
Full TDSGF calculator →
PLD
PLD
● Live price
3.10%
Share price
$132.18
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,750,725.19
Full PLD calculator →

Portfolio growth — TDSGF vs PLD

📍 TDSGF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTDSGFPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TDSGF + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TDSGF pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TDSGF
Annual income on $10K today (after 15% tax)
$472,222.22/yr
After 10yr DRIP, annual income (after tax)
$142,335,872,709,900,260,000.00/yr
PLD
Annual income on $10K today (after 15% tax)
$263.66/yr
After 10yr DRIP, annual income (after tax)
$4,038,116.41/yr
At 15% tax rate, TDSGF beats the other by $142,335,872,709,896,220,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TDSGF + PLD for your $10,000?

TDSGF: 50%PLD: 50%
100% PLD50/50100% TDSGF
Portfolio after 10yr
$86691649649038.95M
Annual income
$83,726,983,947,002,530,000.00/yr
Blended yield
96.58%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

TDSGF
No analyst data
Altman Z
-155.6
Piotroski
1/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+2.9% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TDSGF buys
0
PLD buys
0
No recent congressional trades found for TDSGF or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTDSGFPLD
Forward yield5555.56%3.10%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$173383299298072.00M$5.91M
Annual income after 10y$167,453,967,894,000,300,000.00$4,750,725.19
Total dividends collected$172983452329089.31M$5.78M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: TDSGF vs PLD ($10,000, DRIP)

YearTDSGF PortfolioTDSGF Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$566,256$555,555.56$11,241$540.96+$555.0KTDSGF
2$30,006,493$29,400,599.98$13,019$991.13+$29.99MTDSGF
3$1,488,153,251$1,456,046,302.99$15,801$1,870.97+$1488.14MTDSGF
4$69,079,898,381$67,487,574,402.39$20,609$3,701.21+$69079.88MTDSGF
5$3,001,733,475,908$2,927,817,984,640.30$29,919$7,867.97+$3001733.45MTDSGF
6$122,111,548,308,987$118,899,693,489,765.72$50,631$18,617.74+$122111548.26MTDSGF
7$4,651,108,281,906,614$4,520,448,925,215,998.00$105,528$51,352.20+$4651108281.80MTDSGF
8$165,892,045,974,674,900$160,915,360,113,034,850.00$287,364$174,449.42+$165892045974.39MTDSGF
9$5,541,431,218,758,608,000$5,363,926,729,565,706,000.00$1,081,760$774,280.77+$5541431218757.53MTDSGF
10$173,383,299,298,072,000,000$167,453,967,894,000,300,000.00$5,908,209$4,750,725.19+$173383299298066.09MTDSGF

TDSGF vs PLD: Complete Analysis 2026

TDSGFStock

Telo Genomics Corp., a biotech company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions. It provides telomere analysis platform with diagnostic and prognostic applications; and solutions with liquid biopsies and related technologies in oncology and neurological diseases. The company's lead application is Telo-MM, a solution that provides actionable information to medical professionals in the treatment of Multiple Myeloma, a form of blood cancer. Its solutions also include TeloView, a proprietary software platform used to quantify specific features of each patient's telomeres. The company serves pathologists, clinicians, academic researchers, and drug developers. Telo Genomics Corp. has a collaboration agreement with the Mayo Clinic to validate its Telo-MM tests for multiple myeloma. The company was formerly known as 3D Signatures Inc. and changed its name to Telo Genomics Corp. in April 2019. Telo Genomics Corp. was incorporated in 2014 and is headquartered in Toronto, Canada.

Full TDSGF Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this TDSGF vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TDSGF vs SCHDTDSGF vs JEPITDSGF vs OTDSGF vs KOTDSGF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.